METROPOLITAN LIFE INSURANCE CO/NY - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 61 filers reported holding DESIGN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$12,701
+9.2%
2,0160.0%0.00%0.0%
Q1 2023$11,632
-49.6%
2,016
-10.4%
0.00%0.0%
Q4 2022$23,075
-31.9%
2,249
+11.0%
0.00%
-50.0%
Q3 2022$33,891
+19.4%
2,0270.0%0.00%
+100.0%
Q2 2022$28,378
-13.3%
2,0270.0%0.00%0.0%
Q1 2022$32,736
-81.0%
2,027
-74.8%
0.00%
-50.0%
Q4 2021$172,3088,0480.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,526,476$66,961,64424.44%
Cormorant Asset Management, LP 5,150,000$52,8393.54%
Logos Global Management LP 2,797,501$28,702,3603.36%
RA Capital Management 2,971,231$30,484,8300.62%
Ghost Tree Capital, LLC 82,853$850,0000.36%
Avoro Capital Advisors LLC 2,272,222$23,312,9980.35%
EcoR1 Capital, LLC 884,903$9,079,1050.28%
SILVERARC CAPITAL MANAGEMENT, LLC 57,025$585,0770.17%
Ikarian Capital, LLC 48,500$497,6100.12%
Rock Springs Capital Management LP 460,391$4,723,6120.11%
View complete list of DESIGN THERAPEUTICS INC shareholders